Sign in
4/A

Changes in Ownership

AYTU BIOPHARMA, INC Filed Acc 0001209191-16-139748

Options or other derivatives

  • Chief Operating Officer bought 250,000 shares

From the SEC's structured data for this filing

Trades in this filing

Disbrow Jarrett · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-06 Purchase : show line 1 in the form Warrant to Purchase Common Stock +250,000 250,000 D
Loading xslF345X03/doc4a.xml…